Hospital Corporation of China Ltd (3869) Stock Price & Analysis

1 Followers

3869 Stock Chart & Stats

HK$3.20-HK$0.07(-2.29%)

At close: Nov 11 4:00 PM GMT+8

Day’s Range: HKD 3.20 - HKD 3.20
52-Week Range: HKD 1.00 - HKD 6.66
Previous Close: HKD 3.28
Volume: N/A
Average Volume (3M): 20
Market Cap: HKD 452.59M
Enterprise Value: HKD 961.17M
Total Cash (Recent Filing): HKD 805.00M
Total Debt (Recent Filing): HKD 1.06B
Price to Earnings (P/E): ―
Beta: -0.13
Next Earnings: Mar 31, 2027 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Revenue And Profit Recovery

The sharp 2025 revenue rebound and return to profitability indicate renewed demand for the company’s healthcare services and improved operating execution. If sustained, stronger volumes and earnings can support reinvestment, improve financial resilience, and strengthen the hospital network’s ability to compound results.

Positive Free Cash Flow

Consistently positive free cash flow provides an important internal funding source for hospital operations, capital needs, and debt service. The close relationship between 2025 free cash flow and net income also suggests that the earnings recovery translated into cash, rather than being entirely accounting-driven.

Improved Leverage And Equity Base

The reduction in leverage and increase in equity represent meaningful balance-sheet progress, even though gearing remains elevated. A stronger capital base and recovered return on equity can improve financial flexibility and provide a more stable platform for growth than in the prior high-leverage periods.

Bears Say

High Balance-Sheet Leverage

Debt remains substantial relative to shareholders’ equity, so weaker patient activity, margins, or cash generation could place greater pressure on financial flexibility. Elevated leverage may also restrict the company’s ability to fund expansion internally and makes sustained operating improvement important for balance-sheet stability.

Weak Debt-Coverage Capacity

The decline in free cash flow reduces the company’s near-term capacity to repay debt or finance investment without relying on continued earnings growth. Low operating-cash-flow coverage means deleveraging is likely to be gradual, leaving the business more sensitive to any prolonged weakness in cash conversion.

Volatile Earnings Profile

Although profitability recovered in 2025, margins below the 2023 level show that earnings quality and operating efficiency have not been consistently maintained. This volatility makes future profit conversion less predictable and could limit the durability of the recent recovery if cost pressures or business conditions change.

Hospital Corporation of China Ltd News

Hospital Corporation of China Reshapes Board to Bolster Governance and Compliance

Hospital Corporation of China Ltd ( ($HK:3869) ) has issued an update. Hospital Corporation of China Limited is a Hong Kong-listed healthcare group that operates and invests in hospital and

1M ago3869

Hospital Corporation of China Updates Board and Committee Structure

An update from Hospital Corporation of China Ltd ( ($HK:3869) ) is now available. Hospital Corporation of China Limited has announced the latest composition of its board of directors, detailing

1M ago3869

Hospital Corporation of China Posts Strong Adjusted Profit Despite Flat Revenue

Hospital Corporation of China Ltd ( ($HK:3869) ) has shared an announcement. Hospital Corporation of China Limited reported unaudited interim results for the six months ended 30 June 2026, showing

2M ago3869

Hospital Corporation of China Sets Board Meeting to Review Interim Results and Dividend

An announcement from Hospital Corporation of China Ltd ( ($HK:3869) ) is now available. Hospital Corporation of China Limited has scheduled a board meeting for 25 August 2026 to review

3M ago3869

Hospital Corporation of China Sets Out Board and Committee Structure

The latest announcement is out from Hospital Corporation of China Ltd ( ($HK:3869) ). Hospital Corporation of China Limited has announced the current composition of its board of directors, detailing

4M ago3869

Hospital Corporation of China Reshapes Board After Senior Resignations and Listing Rule Breach

An announcement from Hospital Corporation of China Ltd ( ($HK:3869) ) is now available. Hospital Corporation of China Limited announced significant board changes, including the resignation of chairman and acting

4M ago3869

Hospital Corporation of China Wins Unanimous Shareholder Backing at AGM

Hospital Corporation of China Ltd ( ($HK:3869) ) has shared an announcement. Shareholders of Hospital Corporation of China Limited overwhelmingly backed all resolutions at the annual general meeting held on

4M ago3869

Hospital Corporation of China Sets 2026 AGM, Seeks Share Buyback Mandate and Board Re-elections

Hospital Corporation of China Ltd ( ($HK:3869) ) just unveiled an announcement. Hospital Corporation of China Limited has convened its annual general meeting for 18 June 2026 in Beijing, where

6M ago3869

Hospital Corporation of China Swings to Profit in 2025 but Core Earnings Weaken

Hospital Corporation of China Ltd ( ($HK:3869) ) just unveiled an update. Hospital Corporation of China Limited reported audited consolidated results for the year ended 31 December 2025, showing revenue

7M ago3869

Hospital Corporation of China Seeks Shareholder Approval for Governance Rule Overhaul

The latest announcement is out from Hospital Corporation of China Ltd ( ($HK:3869) ). Hospital Corporation of China Limited plans to update its constitutional documents to modernize governance and better

7M ago3869

3869 FAQ

What was Hospital Corporation of China Ltd’s price range in the past 12 months?

Hospital Corporation of China Ltd lowest stock price was HK$1.00 and its highest was HK$6.66 in the past 12 months.

What is Hospital Corporation of China Ltd’s market cap?

Hospital Corporation of China Ltd’s market cap is HK$452.59M.

When is Hospital Corporation of China Ltd’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Hospital Corporation of China Ltd’s earnings last quarter?

Hospital Corporation of China Ltd released its earnings results on Aug 25, 2026. The company reported HK$0.128 earnings per share for the quarter.

Is Hospital Corporation of China Ltd overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Hospital Corporation of China Ltd pay dividends?

Hospital Corporation of China Ltd does not currently pay dividends.

What is Hospital Corporation of China Ltd’s EPS estimate?

Hospital Corporation of China Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Hospital Corporation of China Ltd have?

Hospital Corporation of China Ltd has 138,194,000 shares outstanding.

What happened to Hospital Corporation of China Ltd’s price movement after its last earnings report?

Hospital Corporation of China Ltd reported an EPS of HK$0.128 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Hospital Corporation of China Ltd?

Currently, no hedge funds are holding shares in HK:3869

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description